Akebia Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Akebia Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $1.4M, unchanged year-over-year.
  • Akebia Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $5.6M, a 11.1% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $5.9M, a 18.1% decline from 2022.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.2M, a 1.41% increase from 2021.
  • Akebia Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $7.1M, a 1.43% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.9M -$1.3M -18.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $7.2M +$100K +1.41% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $7.1M +$100K +1.43% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $7M +$100K +1.45% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 $6.9M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.